Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation

European Journal of Cancer

Volumn 49, Issue 7, 2013, Pages 1692-1705

  Park, Mi Kyung ^a   You, Hye Jin ^b   Lee, He Ja ^a   Kang, Ju Hee ^b   Oh, Seung Hyun ^c   Kim, Soo Youl ^b   Lee, Chang Hoon ^a  

^a Dongguk University   (South Korea)

^b National Cancer Center   (South Korea)

^c Gachon University   (South Korea)

Author keywords

A549 orthotopic model; C Jun N terminal kinase; N cadherin expression; PP2A; TGF 1 induced epithelial mesenchymal transition; Transglutaminase 2

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYSTAMINE; NERVE CELL ADHESION MOLECULE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTHRACENES; BLOTTING, WESTERN; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYSTAMINE; ENZYME ACTIVATION; ENZYME INHIBITORS; EPITHELIAL-MESENCHYMAL TRANSITION; GTP-BINDING PROTEINS; HEK293 CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG NEOPLASMS; MICE; MICE, SCID; PROTEIN PHOSPHATASE 2; RNA INTERFERENCE; TRANSFORMING GROWTH FACTOR BETA1; TRANSGLUTAMINASES; TRANSPLANTATION, HETEROLOGOUS;

EID: 84876120022     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.11.036     Document Type: Article

References (40)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108 (Pubitemid 40372904)
2. M. Sato, D.S. Shames, A.F. Gazdar, and J.D. Minna A translational view of the molecular pathogenesis of lung cancer J Thorac Oncol 2 2007 327 343 (Pubitemid 47181718)
3. J.J. Hung, M.H. Yang, H.S. Hsu, W.H. Hsu, J.S. Liu, and K.J. Wu Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer Thorax 64 2009 1082 1089
4. B.A. Williams, H. Sugimura, and C. Endo Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients Ann Thorac Surg 81 2006 1021 1027 (Pubitemid 43247679)
5. C.E. Denlinger, J.S. Ikonomidis, C.E. Reed, and F.G. Spinale Epithelial to mesenchymal transition: the doorway to metastasis in human lung cancers J Thorac Cardiovasc Surg 140 2010 505 513
6. L. Prudkin, D.D. Liu, and N.C. Ozburn Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung Mod Pathol 22 2009 668 678
7. A. Moustakas, and C.H. Heldin Non-Smad TGF-beta signals J Cell Sci 118 2005 3573 3584
8. R.J. Davis Signal transduction by the JNK group of MAP kinases Cell 103 2000 239 252
9. J.F. Alcorn, A.S. Guala, and J. van der Velden Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1 J Cell Sci 121 2008 1036 1045 (Pubitemid 351639422)
10. J.L. van der Velden, J.F. Alcorn, A.S. Guala, E.C. Badura, and Y.M. Janssen-Heininger C-Jun N-terminal kinase 1 promotes TGF-{beta}1-induced epithelial to mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3 Am J Respir Cell Mol Biol 44 2010 571 581
11. J. Wang, I. Kuiatse, A.V. Lee, J. Pan, A. Giuliano, and X. Cui Sustained c-Jun-NH2-kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activation Mol Cancer Res 8 2010 266 277
12. J.L. McConnell, G.R. Watkins, and S.E. Soss Alpha4 is a ubiquitin-binding protein that regulates protein serine/threonine phosphatase 2A ubiquitination Biochemistry 49 2010 1713 1718
13. M. Kong, D. Ditsworth, T. Lindsten, and C.B. Thompson Alpha4 is an essential regulator of PP2A phosphatase activity Mol Cell 36 2009 51 60
14. L. Xu, and X. Deng Suppression of cancer cell migration and invasion by protein phosphatase 2A through dephosphorylation of mu- and m-calpains J Biol Chem 281 2006 35567 35575 (Pubitemid 46036590)
15. P.H. Huang, D. Wang, H.C. Chuang, S. Wei, S.K. Kulp, and C.S. Chen Alpha-tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis Carcinogenesis 30 2009 1125 1131
16. S.Y. Kim Transglutaminase 2: a new paradigm for NF-kappaB involvement in disease Adv Enzymol Relat Areas Mol Biol 78 2011 161 195
17. C.H. Lee, and S.Y. Kim NF-kB and therapeutic approach Biomolecules & Therapeutics 17 2009 219 240
18. V.G. Keshamouni, G. Michailidis, and C.S. Grasso Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype J Proteome Res 5 2006 1143 1154 (Pubitemid 43727792)
19. M. Shao, L. Cao, and C. Shen Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase Cancer Res 69 2009 9192 9201
20. A. Kumar, J. Xu, and S. Brady Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cells PLoS One 5 2010 e13390
21. A. Kumar, J. Xu, and B. Sung Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to- mesenchymal transition in mammary epithelial cells Breast Cancer Res 14 2012 R4
22. C.Y. Lin, P.H. Tsai, and C.C. Kandaswami Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells Mol Cancer 10 2011 87
23. Y.D. Park, C.H. Jin, D.S. Choi, M.W. Byun, and I.Y. Jeong Biological evaluation of isoegomaketone isolated from Perilla frutescens and its synthetic derivatives as anti-inflammatory agents Arch Pharm Res 34 2011 1277 1282
24. M.S. Koh, J.S. Hwang, and A. Moon Lycopene inhibits proliferation, invasion and migration of human breast cancer cells Biomol Ther 18 2010 92 98
25. A. Onn, T. Isobe, S. Itasaka, W. Wu, and M.S. O'Reilly Ki Hong W, et al. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice Clin Cancer Res 9 2003 5532 5539 (Pubitemid 37499472)
26. M.K. Park, H.J. Lee, J. Shin, M.S. Noh, S.Y. Kim, and C.H. Lee Novel participation of transglutaminase-2 through c-Jun N-terminal kinase activation in sphingosylphosphorylcholine-induced keratin reorganization of PANC-1 cells Biochim Biophys Acta 1811 2011 1021 1029
27. C.M. Choi, S.J. Jang, and S.Y. Park Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer Mol Cancer 10 2011 119
28. J.H. Kim, Y.S. Jang, and K.S. Eom Transforming growth factor beta1 induces epithelial-to-mesenchymal transition of A549 cells J Korean Med Sci 22 2007 898 904
29. S. Le Mee, O. Fromigue, and P.J. Marie Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts Exp Cell Res 302 2005 129 142 (Pubitemid 39482374)
30. M. Yamauchi, I. Yoshino, and R. Yamaguchi N-cadherin expression is a potential survival mechanism of gefitinib-resistant lung cancer cells Am J Cancer Res 1 2011 823 833
31. A. Wells, Y.L. Chao, J. Grahovac, Q. Wu, and D.A. Lauffenburger Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis Front Biosci 16 2011 815 837
32. R.T. Bryan, and C. Tselepis Cadherin switching and bladder cancer J Urol 184 2010 423 431
33. P.T. Nguyen, Y. Kudo, M. Yoshida, N. Kamata, I. Ogawa, and T. Takata N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition Histol Histopathol 26 2011 147 156
34. L.W. Cheung, P.C. Leung, and A.S. Wong Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer Oncogene 29 2010 2427 2440
35. M. Maeda, K.R. Johnson, and M.J. Wheelock Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition J Cell Sci 118 2005 873 887 (Pubitemid 40484880)
36. C. Cellurale, G. Sabio, and N.J. Kennedy Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation Mol Cell Biol 31 2011 1565 1576
37. A.P. Morel, G.W. Hinkal, and C. Thomas EMT Inducers Catalyze Malignant Transformation of Mammary Epithelial Cells and Drive Tumorigenesis towards Claudin-Low Tumors in Transgenic Mice PLoS Genet 8 2012 e1002723
38. M. Satpathy, M. Shao, R. Emerson, D.B. Donner, and D. Matei Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity J Biol Chem 284 2009 15390 15399
39. A. Verma, S. Guha, and H. Wang Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells Clin Cancer Res 14 2008 1997 2005 (Pubitemid 351551108)
40. K. Kondo, H. Fujino, T. Miyoshi, H. Ishikura, S. Sakiyama, and Y. Monden Orthotopically implanted SCID mouse model of human lung cancer suitable for investigating metastatic potential and anticancer drug effects Oncol Rep 12 2004 991 999